Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGM - Nasdaq Real Time Price USD

STAAR Surgical Company (STAA)

19.44
+0.80
+(4.29%)
At close: May 7 at 4:00:00 PM EDT
18.31
-1.13
(-5.81%)
Pre-Market: 4:19:13 AM EDT

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Stephen C. Farrell CFA CEO & Director 115k -- 1965
Mr. Warren Foust President & COO 595.87k -- 1976
Mr. Nathaniel B. Sisitsky Esq. Senior VP, Chief Legal Officer, General Counsel & Corporate Secretary 486.97k -- 1974
Dr. Magda Michna Ph.D. Chief Development Officer and Chief Clinical, Regulatory & Medical Affairs Officer 569.73k -- --
Mr. Thomas G. Frinzi Advisor 821.22k -- 1956
Ms. Deborah J. Andrews Interim Chief Financial Officer 755.3k 3.72M 1957
Mr. Brian Moore Vice President of Investor Relations & Corporate Development -- -- --
Ms. Nancy Sabin Chief Marketing Officer -- -- --
Mr. James Francese Senior Vice President of Commercial Operations - North America & APAC 755.65k 882.3k 1964
Dr. Scott D. Barnes M.D. Chief Medical Officer 691.15k -- 1963

STAAR Surgical Company

25510 Commercentre Drive
Lake Forest, CA 92630
United States
626 303 7902 https://www.staar.com
Sector: 
Healthcare
Full Time Employees: 
1,157

Description

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Corporate Governance

STAAR Surgical Company’s ISS Governance QualityScore as of May 1, 2025 is 8. The pillar scores are Audit: 9; Board: 3; Shareholder Rights: 7; Compensation: 10.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

August 5, 2025 at 10:59 AM UTC - August 11, 2025 at 12:00 PM UTC

STAAR Surgical Company Earnings Date

Recent Events

May 7, 2025 at 12:00 AM UTC

10-Q: Periodic Financial Reports

April 24, 2025 at 12:00 AM UTC

DEF 14A: Proxy Statements

March 18, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

February 21, 2025 at 12:00 AM UTC

10-K: Periodic Financial Reports

February 11, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

January 13, 2025 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

November 12, 2024 at 12:00 AM UTC

SC 13G/A: Tender Offer/Acquisition Reports

October 31, 2024 at 12:00 AM UTC

8-K/A: Corporate Changes & Voting Matters

October 30, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 7, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

Related Tickers